Treatment of chronic hepatitis B in australia and New Zealand

J Gastroenterol Hepatol. 2000 May:15 Suppl:E79-82. doi: 10.1046/j.1440-1746.2000.02105.x.

Author

N Stace¹

Affiliation

¹ Department of Gastroenterology, Wellington School of Medicine, Newtown, New Zealand. wounhs@wnhealth.co.nz

PMID: 10921387
DOI: 10.1046/j.1440-1746.2000.02105.x

No abstract available

MeSH terms

Antiviral Agents / therapeutic use
Australia / epidemiology
Hepatitis B, Chronic / diagnosis
Hepatitis B, Chronic / epidemiology
Hepatitis B, Chronic / therapy*
Humans
Interferon-alpha / therapeutic use
New Zealand / epidemiology
Plants, Medicinal

Substances

Antiviral Agents
Interferon-alpha